Ładuje się......
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Korean Society for Radiation Oncology
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797277/ https://ncbi.nlm.nih.gov/pubmed/24137563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2013.31.3.171 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|